Suppr超能文献

基因组分析在破解冠状病毒大流行中的重要性。

The importance of genomic analysis in cracking the coronavirus pandemic.

机构信息

Institute of Human Virology, Department of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, USA.

, Member of the Global Virus Network, Baltimore, USA.

出版信息

Expert Rev Mol Diagn. 2021 Jun;21(6):547-562. doi: 10.1080/14737159.2021.1917998. Epub 2021 Apr 28.

Abstract

: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has pushed the scientific community to undertake intense research efforts. Understanding SARS-CoV-2 biology is necessary to discover therapeutic or preventive strategies capable of containing the pandemic. Knowledge of the structural characteristics of the virus genome and proteins is essential to find targets for therapies and immunological interventions.: This review covers different areas of expertise, genomic analysis of circulating strains, structural biology, viral mutations, molecular diagnostics, disease, and vaccines. In particular, the review is focused on the molecular approaches and modern clinical strategies used in these fields.: Molecular approaches to SARS-CoV-2 pandemic have been critical to shorten time for new diagnostic, therapeutic and prevention strategies. In this perspective, the entire scientific community is moving in the same direction. Vaccines, together with the development of new drugs to treat the disease, represent the most important strategy to protect human from viral disease and prevent further spread. In this regard, new molecular technologies have been successfully implemented. The use of a novel strategy of communication is suggested for a better diffusion to the broader public of new data and results.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)大流行促使科学界进行了密集的研究工作。了解 SARS-CoV-2 的生物学特性对于发现能够控制大流行的治疗或预防策略是必要的。了解病毒基因组和蛋白质的结构特征对于寻找治疗和免疫干预的靶点至关重要。

本综述涵盖了不同的专业领域,包括循环株的基因组分析、结构生物学、病毒突变、分子诊断、疾病和疫苗。特别是,该综述重点介绍了这些领域中使用的分子方法和现代临床策略。

分子方法在 SARS-CoV-2 大流行中至关重要,可以缩短新的诊断、治疗和预防策略的时间。在这方面,整个科学界都在朝着同一个方向前进。疫苗以及开发治疗这种疾病的新药是保护人类免受病毒疾病侵害并防止进一步传播的最重要策略。在这方面,已经成功实施了新的分子技术。建议采用新的沟通策略,以便更广泛地向公众传播新的数据和结果。

相似文献

1
The importance of genomic analysis in cracking the coronavirus pandemic.
Expert Rev Mol Diagn. 2021 Jun;21(6):547-562. doi: 10.1080/14737159.2021.1917998. Epub 2021 Apr 28.
3
4
The variants question: What is the problem?
J Med Virol. 2021 Dec;93(12):6479-6485. doi: 10.1002/jmv.27196. Epub 2021 Jul 28.
5
Mutation profile of SARS-CoV-2 genome in a sample from the first year of the pandemic in Colombia.
Infect Genet Evol. 2022 Jan;97:105192. doi: 10.1016/j.meegid.2021.105192. Epub 2021 Dec 18.
6
Emergence of novel SARS-CoV-2 variants in the Netherlands.
Sci Rep. 2021 Mar 23;11(1):6625. doi: 10.1038/s41598-021-85363-7.
8
Will the emergent SARS-CoV2 B.1.1.7 lineage affect molecular diagnosis of COVID-19?
J Med Virol. 2021 May;93(5):2566-2568. doi: 10.1002/jmv.26823. Epub 2021 Feb 9.
9
SARS-CoV-2 Lineages and Sub-Lineages Circulating Worldwide: A Dynamic Overview.
Chemotherapy. 2021;66(1-2):3-7. doi: 10.1159/000515340. Epub 2021 Mar 18.
10
SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.
Int Rev Immunol. 2023;42(6):393-414. doi: 10.1080/08830185.2022.2079642. Epub 2022 May 28.

引用本文的文献

1
Vaccination Strategies in Respiratory Diseases: Recommendation from AIPO-ITS/ETS, SIMIT, SIP/IRS, and SItI.
Respiration. 2025;104(8):556-574. doi: 10.1159/000544919. Epub 2025 Mar 9.
2
Effect of COVID-19 vaccine in adults infected with the Delta variant of SARS-CoV-2: a retrospective cohort study.
J Thorac Dis. 2024 Oct 31;16(10):6983-6998. doi: 10.21037/jtd-24-1351. Epub 2024 Oct 15.
3
Anticoagulant therapy in adult with COVID-19: a systematic review and meta-analysis of randomized controlled trial.
J Thorac Dis. 2024 Oct 31;16(10):6391-6405. doi: 10.21037/jtd-24-744. Epub 2024 Oct 17.
4
Effects of Contagious Respiratory Pathogens on Breath Biomarkers.
Antioxidants (Basel). 2024 Jan 29;13(2):172. doi: 10.3390/antiox13020172.
5
A New-fangled COVID-19 Variant, Eris, Might be the One to Lookout in 2023 or far from Over.
Infect Disord Drug Targets. 2024;24(6):e220124225916. doi: 10.2174/0118715265276833240105110046.
6
Transchromosomic bovine-derived anti-SARS-CoV-2 polyclonal human antibodies protects hACE2 transgenic hamsters against multiple variants.
iScience. 2023 Aug 29;26(10):107764. doi: 10.1016/j.isci.2023.107764. eCollection 2023 Oct 20.
7
Clinical Investigation of Leukocyte DNA Damage in COVID-19 Patients.
Curr Issues Mol Biol. 2023 Jan 19;45(2):963-974. doi: 10.3390/cimb45020062.
8
Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients.
Front Nutr. 2022 Jan 12;8:756177. doi: 10.3389/fnut.2021.756177. eCollection 2021.
9
A Multiallelic Molecular Beacon-Based Real-Time RT-PCR Assay for the Detection of SARS-CoV-2.
Life (Basel). 2021 Oct 27;11(11):1146. doi: 10.3390/life11111146.

本文引用的文献

1
Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 with grinch.
Wellcome Open Res. 2021 Sep 17;6:121. doi: 10.12688/wellcomeopenres.16661.2. eCollection 2021.
2
Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2.
PLoS Biol. 2021 May 7;19(5):e3001236. doi: 10.1371/journal.pbio.3001236. eCollection 2021 May.
3
SARS-CoV-2 Infection and the COVID-19 Pandemic Emergency: The Importance of Diagnostic Methods.
Chemotherapy. 2021;66(1-2):17-23. doi: 10.1159/000515343. Epub 2021 Mar 19.
4
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.
N Engl J Med. 2021 Apr 15;384(15):1468-1470. doi: 10.1056/NEJMc2102179. Epub 2021 Mar 17.
5
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
N Engl J Med. 2021 May 20;384(20):1885-1898. doi: 10.1056/NEJMoa2102214. Epub 2021 Mar 16.
6
Detection of a SARS-CoV-2 variant of concern in South Africa.
Nature. 2021 Apr;592(7854):438-443. doi: 10.1038/s41586-021-03402-9. Epub 2021 Mar 9.
7
Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2.
Biochem Biophys Res Commun. 2021 Jan 29;538:116-124. doi: 10.1016/j.bbrc.2020.10.045. Epub 2020 Oct 21.
8
Neutralizing Activity of BNT162b2-Elicited Serum.
N Engl J Med. 2021 Apr 15;384(15):1466-1468. doi: 10.1056/NEJMc2102017. Epub 2021 Mar 8.
9
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.
Emerg Infect Dis. 2021 May;27(5):1522-1524. doi: 10.3201/eid2705.210191. Epub 2021 Feb 19.
10
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.
Science. 2021 Mar 12;371(6534):1152-1153. doi: 10.1126/science.abg6105. Epub 2021 Jan 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验